Measuring the impact of marketing authorisation withdrawal and revocation on public health in France, Germany and UK

Aug-21

AUTHORS : Samantha Lane, Drug Safety Research Unit DSRU, Bursledon Hall, Blundell Lane, Southampton SO31 1AA, U.K – Email: samantha.lane@dsru.org – Profile: https://www.dsru.org/service/samantha-lane/ AND https://www.dsru.org/author/samantha-lanedsru-org/

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 30(S1):S269-S270

DOI : 10.1002/pds.5305

Measuring the impact of marketing authorisation withdrawal and revocation on public health in France, Germany and UK

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

The risk of immune-mediated inflammatory diseases following exposure to childhood maltreatment: a retrospective cohort study using UK primary care data